Fiona Pathiraja
Angel Investor · at Crista Galli Ventures
Fiona Pathiraja is a seed investor at Crista Galli Ventures focused on Health Care and Software. Fiona is Managing Partner at Crista Galli Ventures, an early stage healthtech VC fund based in London and Copenhagen.
- Total investments:
- 15
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Fiona Pathiraja invests in
Stages Fiona Pathiraja invests in
Countries Fiona Pathiraja invests in
Round sizes
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Round size
- Seed
- $1.1M–$4.5M
- Pre-Seed
- $840k–$2.5M
- Series A
- $10M–$12M
Investment Focus
Industry
- Health Care 10 (67%)
- Software 4 (27%)
- Medical 3 (20%)
- Artificial Intelligence 3 (20%)
- Apps 2 (13%)
Stage
- Seed 6 (40%)
- Pre-Seed 6 (40%)
- Series A 2 (13%)
- Venture - Series Unknown 1 (7%)
Country
- United Kingdom 9 (60%)
- Germany 2 (13%)
- Austria 1 (7%)
- Denmark 1 (7%)
- Switzerland 1 (7%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Everyman Health ist Spezialist für Männergesundheit und bietet wissenschaftlich fundierte Lösungen für Männer aller Altersgruppen. In Zusammenarbeit mit unseren Partnern, bieten wir dir ein umfassendes Portfolio von digitalen, medikamentösen und nicht-medikamentösen Therapien für unterschiedliche Männerprobleme.Über unsere Plattform wirst du inwenigen Minuten mit einem Schweizer Facharzt verbunden und erhältst eine persönliche Diagnose und gegebenenfalls ein Rezept.Auf Wunsch wird deine persönliche Behandlung von einer lizenzierten Schweizer Apotheke diskret verpackt und dir kostenlos bis vor die Haustür geliefert. | $2.7M / Seed / Nov 27, 2024 | ||
| Unfabled is a women’s health consumer platform that delivers curated and personalised solutions. | $1.6M / Seed / Feb 06, 2024 | ||
| Juniver provides on-demand help, specialized care, and a supportive network for long-term recovery from eating disorders. | $1.2M / Pre-Seed / Oct 21, 2023 | ||
| Hey, we're Jude. A healthcare start-up on a mission is to bring bladder care into the mainstream. | $4.5M / Seed / Sep 03, 2023 | ||
| Bloom Money is a savings club app designed to help growing communities in migrant communities and use technology to promote community, safety, and convenience. | $1.3M / Pre-Seed / Jul 27, 2023 | ||
| Storia is guided journaling software that helps people uncover their authentic voice. The journaling app combines AI-guided prompts, on-demand sessions, reflections, and community to help users recover their inner narratives, build self-awareness, and cultivate a stronger connection with their real selves. | Pre-Seed / May 24, 2023 | ||
| Melon is an AI learning platform to help you find your inner thought leader. Save videos, articles, and whatever else to personalized collections and use Melon's AI thought partner to see connect the dots between what you're learning. | $1.5M / Pre-Seed / Dec 06, 2022 | ||
| Daye has set out to build a new brand for female health products “designed with women in mind.” The startup’s first product is a newly developed tampon that uses CBD to help tackle period cramps (or dysmenorrhea) as an alternative to traditional painkillers (CBD is the extract derived from the flower of the industrial hemp plant, a legal relativeto marijuana). | $11.6M / Series A / Oct 26, 2022 | ||
| Holly Health helps individuals to change their health intentions into clear daily actions, for mental and physical wellbeing. The service is fully digital, yet personalised and compassionate, using proprietary AI systems, to mimic the role of a human health coach. Rated within the top 3 health apps for weight management, stress reduction, wellnessand sleep, by ORCHA (the world's leading health app evaluation organisation), with a score of 89%!Having launched internationally to consumers in Summer 2021, the Holly Health team is on a mission to support 5 million people by 2025. Holly Health is currently rolling out with primary care practices in the UK, with over 100 partnerships already in place. Reach out to hello@hollyhealth.io to find out more. | $1.1M / Seed / Jul 01, 2022 | ||
| Inne is a Berlin-based biotech startup that builds a hormone-based mini lab for women with a mission to make natural contraception convenient and accurate. They aim to help women tune into their bodies and make informed decisions about their fertility and overall female health.Inne uses biochemistry and an app to track hormones and understandwhat it means and how they affect a woman's everyday fertility. | $10M / Series A / May 25, 2022 | ||
| See all 15 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Fiona Pathiraja invest in?
Fiona Pathiraja invests primarily in Health Care, Software and Medical startups, most often at Seed and Pre-Seed stage. Most of the 15 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Fiona Pathiraja invest in?
Fiona Pathiraja typically joins rounds of $1.1M–$4.5M at Seed, $840k–$2.5M at Pre-Seed and $10M–$12M at Series A. These are whole funding-round sizes, not Fiona Pathiraja's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Fiona Pathiraja took part in.
How do I contact Fiona Pathiraja?
Public channels for Fiona Pathiraja include LinkedIn and X (Twitter). For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Fiona Pathiraja last invest?
The most recent investment recorded for Fiona Pathiraja closed in Nov 2024. Shizune tracks 15 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
